BPC-157
BPC-157 Price range: $24.00 through $40.00
Back to products
AOD9604
AOD9604 Original price was: $55.00.Current price is: $44.00.

Ara-290 (10mg)

15 BOUGHT IN LAST 24H

Original price was: $49.50.Current price is: $39.60.

59 in stock

🎖 Verified veterans save 15% — for life. Learn More →
99%+ Purity Guaranteed
VETERAN MISSION
Same-Day
Shipping
Third-Party
Tested
Secure
Checkout
SCIENTIFIC SPECIFICATIONS
Molecular Formula
C512H84N16O21
CAS
1208243-50-8
Molar Mass
1257.3 g/mol
Chemical Formula
C78H123N23O21S
Amino Acid Sequence
Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
Synonyms
Pyroglutamate Helix B Surface Peptide, pHBSP, ARA 290, Cibinetide
Solubility
Water-soluble
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder – requires reconstitution
Research Use Only
● VERIFIED ANALYSIS

Third-Party Lab Results

Transparency is our priority. Download the full HPLC and Mass Spectrometry reports for the current batch #88291. Tested on Oct 24, 2023.

DOWNLOAD FULL REPORT (PDF)
PDF
HPLC_BPC157_Batch88291.pdf
Verified by Janoshik
PDF
MS_BPC157_Batch88291.pdf
Verified by Janoshik
Research Overview

ARA-290 is a small peptide derived from the structure of erythropoietin (EPO) and designed to selectively engage tissue-protective signaling pathways without the hematopoietic effects typically associated with EPO. In research settings, ARA-290 is primarily investigated for its interaction with the so-called innate repair receptor (IRR) and tissue-protective receptor (TPR), where it has been shown in preclinical and early clinical studies to influence inflammatory signaling, vascular repair mechanisms, neuropathic pain pathways, and wound-healing processes.

Supplied strictly as a research compound, ARA-290 is intended for use in controlled laboratory experiments only. It is not approved for human or veterinary consumption, diagnosis, treatment, or prevention of any disease.

ARA-290 is a non-erythropoietic EPO analogue engineered to retain tissue-protective and anti-inflammatory properties while minimizing effects on red blood cell production and cardiovascular parameters. By targeting specific EPO-related receptor complexes (often referred to as IRR/TPR), ARA-290 is used to explore:

  • Modulation of inflammatory cytokine release
  • Protection and repair of vascular and endothelial cells
  • Regulation of immune-cell activity and antigen presentation
  • Neural repair mechanisms and small fiber nerve integrity
  • Wound repair and tissue regeneration in ischemic or inflammatory environments

Preclinical and translational research has examined ARA-290 in models of vascular injury, islet transplantation, autoimmune conditions, neuropathic pain, and small fiber neuropathy, making it a versatile tool for studying tissue protection and immune modulation.

 

Storage & Handling

All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.

  • On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
  • Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
  • After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.

Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.

FAQ 

Q1: What is ARA-290 in a research context?
A1: ARA-290 is a non-erythropoietic peptide derived from erythropoietin, used in research to study tissue protection, immune modulation, vascular repair, and neuropathic pain mechanisms via the innate repair/tissue-protective receptor pathways.

Q2: What are the main experimental applications of ARA-290?
A2:
Common research applications include models of vascular and endothelial repair, islet transplantation, autoimmune and inflammatory diseases, neuropathic pain, small fiber neuropathy, and wound healing in metabolic disease.

Q3: How does ARA-290 differ from full-length erythropoietin (EPO)?
A3: ARA-290 is designed to selectively activate tissue-protective receptor complexes without stimulating the hematopoietic and many cardiovascular effects associated with full-length EPO, making it more suitable for focused tissue-protection and immune-modulation research.

Q4: Is ARA-290 intended for human or veterinary use?
A4: No. ARA-290 from research suppliers is for laboratory use only and is not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

Q5: Why is ARA-290 of interest in neuropathy research?
A5:
ARA-290 has been studied for its effects on small nerve fiber integrity, inflammatory signaling, and TRPV1-related pain pathways, making it a valuable compound for investigating mechanisms underlying neuropathic pain and small fiber neuropathy in controlled studies.

 

i
Research Use Only: This product is intended for laboratory research use only and is not for human consumption, diagnostic, or therapeutic use.

Researcher Reviews